CIBC Bank USA’s Elevance Health ELV Stock Holding History

CIBC Bank USA’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,630	Closed	-$205K	–	278
2014 Q4	$205K	Buy	+1,630	New	+$201K	0.04%	273

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

CIBC Bank USA's ELV Position: Q1 2015 in Review

CIBC Bank USA sold out of Elevance Health (ELV) in Q1 2015, closing a stake of 1,630 shares — an estimated $205K sold.

CIBC Bank USA first reported a position in ELV in Q4 2014 and held it in 1 quarter. The position peaked at $205K in Q4 2014. 752 funds tracked by Wall St. Rank hold ELV as of Q1 2015.

CIBC Bank USA reported no remaining Elevance Health position as of Q1 2015 after selling out during the quarter.
CIBC Bank USA sold 1,630 Elevance Health shares in Q1 2015, an estimated $205K.
CIBC Bank USA first reported a position in Elevance Health in Q4 2014 and held it in 1 quarter.
CIBC Bank USA's Elevance Health position peaked at $205K in Q4 2014.
752 funds tracked by Wall St. Rank held Elevance Health as of Q1 2015.

Based on CIBC Bank USA's 13F filing for Q1 2015, filed 9 Apr 2015.